Healthcare provider profile · identity verified

Sherry Lee Kroll, MD

Internal Medicine · PLAINFIELD, CT · NPI 1922178557

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	524	156
Levothyroxine Sodium	Levothyroxine Sodium	395	114
Losartan Potassium	Losartan Potassium	382	116
Gabapentin	Gabapentin	327	90
Amlodipine Besylate	Amlodipine Besylate	295	94
Omeprazole	Omeprazole	288	91
Lisinopril	Lisinopril	278	84
Simvastatin	Simvastatin	223	76
Montelukast Sodium	Montelukast Sodium	183	56
Metoprolol Succinate	Metoprolol Succinate	179	57
Rosuvastatin Calcium	Rosuvastatin Calcium	174	57
Trazodone Hcl	Trazodone Hcl	171	51
Sertraline Hcl	Sertraline Hcl	165	55
Hydrochlorothiazide	Hydrochlorothiazide	148	49
Eliquis	Apixaban	147	34
Escitalopram Oxalate	Escitalopram Oxalate	147	41
Duloxetine Hcl	Duloxetine Hcl	140	36
Furosemide	Furosemide	124	41
Metformin Hcl	Metformin Hcl	124	37
Metoprolol Tartrate	Metoprolol Tartrate	107	34
Pravastatin Sodium	Pravastatin Sodium	105	31
Metformin Hcl Er	Metformin Hcl	104	36
Alendronate Sodium	Alendronate Sodium	101	32
Fluticasone Propionate	Fluticasone Propionate	91	34
Spironolactone	Spironolactone	90	28
Jardiance	Empagliflozin	79	27
Pantoprazole Sodium	Pantoprazole Sodium	78	31
Albuterol Sulfate Hfa	Albuterol Sulfate	69	35
Atenolol	Atenolol	68	24
Meloxicam	Meloxicam	66	24
Ozempic	Semaglutide	64	12
Celecoxib	Celecoxib	62	22
Famotidine	Famotidine	61	22
Synthroid	Levothyroxine Sodium	58	19
Bupropion Xl	Bupropion Hcl	57	13
Ropinirole Hcl	Ropinirole Hcl	55	suppressed
Carvedilol	Carvedilol	52	19
Tramadol Hcl	Tramadol Hcl	52	16
Ezetimibe	Ezetimibe	49	14
Glipizide Er	Glipizide	46	13
Lovastatin	Lovastatin	45	12
Lorazepam	Lorazepam	44	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	13
Alprazolam	Alprazolam	41	15
Citalopram Hbr	Citalopram Hydrobromide	38	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	15
Diclofenac Sodium	Diclofenac Sodium	37	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Paroxetine Hcl	Paroxetine Hcl	37	14
Allopurinol	Allopurinol	35	12
Valsartan	Valsartan	35	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	17
Lansoprazole	Lansoprazole	31	11
Buspirone Hcl	Buspirone Hcl	30	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	28	suppressed
Cevimeline Hcl	Cevimeline Hcl	27	suppressed
Mounjaro	Tirzepatide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Prednisone	Prednisone	23	18
Topiramate	Topiramate	23	suppressed
Baclofen	Baclofen	22	suppressed
Mometasone Furoate	Mometasone Furoate	22	11
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Irbesartan	Irbesartan	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	20
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Potassium Chloride	Potassium Chloride	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Naproxen	Naproxen	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Finasteride	Finasteride	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Azithromycin	Azithromycin	16	14
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lactulose	Lactulose	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	14	suppressed
Glipizide	Glipizide	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Desloratadine	Desloratadine	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Levemir Flexpen	Insulin Detemir	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Carbatrol	Carbamazepine	12	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Estradiol	Estradiol	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Prolia	Denosumab	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error